Kaisa Lehtomäki

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

Pia Österlund, Leena-Maija Soveri, Raija Kallio et al. · The Lancet Regional Health - Europe · 2021 · 108 citations · Full text

Medicine, Oncology, Surgery +16

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

Kaisa Lehtomäki, Harri Mustonen, Pirkko‐Liisa Kellokumpu‐Lehtinen et al. · Cancers · 2021 · 20 citations · Full text

Medicine, Oncology, Chemotherapy +13

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Kaisa Lehtomäki, Hanna Stedt, Emerik Österlund et al. · Cancers · 2022 · 20 citations · Full text

Medicine, Oncology, Surgery +17

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

Aki Uutela, Emerik Österlund, Päivi Halonen et al. · British Journal of Cancer · 2022 · 18 citations · Full text

Medicine, Oncology, Surgery +17

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

Aki Uutela, Ali Ovissi, Antti Hakkarainen et al. · ESMO Open · 2021 · 16 citations · Full text

Medicine, Oncology, Radiology +17